Cytokinetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.

About CYTK

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.

CEO

Robert I. Blum

CEORobert I. Blum

Employees

498

Employees498

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

1997

Founded1997

Employees

498

Employees498

CYTK Key Statistics

Market cap

8.33B

Market cap8.33B

Price-Earnings ratio

-10.80

Price-Earnings ratio-10.80

Dividend yield

—

Dividend yield—

Average volume

1.80M

Average volume1.80M

High today

$69.33

High today$69.33

Low today

$67.19

Low today$67.19

Open price

$68.60

Open price$68.60

Volume

521.04K

Volume521.04K

52 Week high

$69.33

52 Week high$69.33

52 Week low

$29.31

52 Week low$29.31

Stock Snapshot

The current Cytokinetics(CYTK) stock price is $68.13, with a market capitalization of 8.33B. The stock trades at a price-to-earnings (P/E) ratio of -10.80.

On 2025-11-29, Cytokinetics(CYTK) stock traded between a low of $67.19 and a high of $69.33. Shares are currently priced at $68.13, which is +1.4% above the low and -1.7% below the high.

Cytokinetics(CYTK) shares are trading with a volume of 521.04K, against a daily average of 1.8M.

During the past year, Cytokinetics(CYTK) stock moved between $29.31 at its lowest and $69.33 at its peak.

Analyst ratings

81%

of 21 ratings

Buy

81%

Hold

19%

Sell

People also own

Based on the portfolios of people who own CYTK. This list is generated using Robinhood data, and it’s not a recommendation.